GLP3-R (Retatrutide) – 10 mg [For Laboratory Research Use Only]
GLP3-R (Retatrutide) is a peptide-based material supplied for controlled laboratory research applications involving multi-receptor incretin activity, metabolic regulation, and energy expenditure pathways. This material is presented for investigational use in qualified research settings only.
Retatrutide is a synthetic peptide commonly studied as a triple hormone receptor agonist. It is engineered to simultaneously engage the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCG) receptors. In laboratory environments, it may be evaluated for receptor binding affinity, metabolic signaling responses, lipolysis activation, and other experimental endpoints relevant to preclinical research.
Research Applications
In laboratory settings, researchers may study this material in connection with:
- Triple-agonist receptor binding (GLP-1R, GIPR, and GCGR)
- Metabolic regulation and energy expenditure models
- Hepatic lipid metabolism and fat reduction pathways
- Insulin secretion and glycemic control signaling
- Appetite regulation and satiety pathways in neurological modeling
Research Assumptions for Laboratory Evaluation
Depending on the experimental model and protocol, laboratory researchers may evaluate:
- Cellular signaling changes following simultaneous multi-receptor exposure
- Variations in dose-response behavior in metabolic and physiological models
- Peptide stability, half-life, and degradation rates
- Synergistic effects of concurrent GIP, GLP-1, and glucagon receptor activation
- Biochemical observations in controlled in vitro or in vivo experimental systems
These are research-focused areas of investigation only and do not represent product claims for consumer use.
Product Specifications
- Research Reference Strength: 10 mg per vial
- Peptide Identification: Retatrutide (LY3437943)
- Molecular Formula: C₂₂₃H₃₄₃N₄₆O₇₀ (approximate base structure)
- Molecular Weight: 4731.3 g/mol
- CAS Number: 2381089-83-2
Mechanism of Research Interest
Experimental interest in Retatrutide focuses on its unique "tri-agonist" mechanism. While GLP-1 and GIP agonism are studied for their roles in insulin release and appetite suppression, the addition of glucagon receptor agonism provides a novel research pathway for investigating increased energy expenditure and direct hepatic lipid metabolism. This makes it a highly valuable compound for metabolic and cellular energy research.
Research Use Only Notice
Important: This product is intended strictly for laboratory research purposes only.
- Not for human or animal consumption
- Not for diagnostic, therapeutic, or clinical use
- Not intended to prevent, treat, mitigate, or cure any disease or condition
- To be handled only by qualified professionals in appropriate research settings
This material is supplied through a third-party source. RevGenetics does not manufacture this material and does not independently verify or validate third-party descriptions, specifications, or claims beyond presenting the information supplied by that source. RevGenetics does not endorse any use outside of lawful, controlled research environments.
The purchaser assumes all responsibility for the safe handling, storage, and use of this material. Misuse is solely the responsibility of the purchaser. All sales of research materials are final. No refunds or returns are permitted.
By purchasing this product, the customer acknowledges and agrees that the material is being obtained solely for lawful laboratory research use and subject to the applicable Terms and Conditions.
